The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) is a potent inhibitor of human immunodeficiency virus (HIV) replication and syncytium formation in vitro. However, the exact mechanism of action of NB-DNJ remains to be determined. In this study we have examined the impairment of HIV i...

Descrición completa

Detalles Bibliográficos

Publicado en:	J Virol
Principais autores:	Fischer, P B, Collin, M, Karlsson, G B, James, W, Butters, T D, Davis, S J, Gordon, S, Dwek, R A, Platt, F M
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189444/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7543588/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.9.5791-5797.1995
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!